Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention

Journal of the American College of Cardiology

Volumn 61, Issue 3, 2013, Pages 295-301

  Hlatky, Mark A ^a   Solomon, Matthew D ^a,b   Shilane, David ^a   Leong, Thomas K ^b   Brindis, Ralph ^c   Go, Alan S ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adherence; CABG; PCI; secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG USE; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHARMACEUTICAL CARE; PRESCRIPTION; PRIORITY JOURNAL; SECONDARY PREVENTION; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CHEMOPREVENTION; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RECURRENCE; SECONDARY PREVENTION; TICLOPIDINE;

EID: 84872333760     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.10.018     Document Type: Article

References (29)

1. S.C. Smith, E.J. Benjamin, R.O. Bonow AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update A guideline from the American Heart Association and American College of Cardiology Foundation J Am Coll Cardiol 58 2011 2432 2446
2. L.D. Hillis, P.K. Smith, J.L. Anderson 2011 ACCF/AHA guideline for coronary artery bypass graft surgery A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 e123 e210
3. G.N. Levine, E.R. Bates, J.C. Blankenship 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 58 2011 e44 e122
4. V.L. Roger, A.S. Go, D.M. Lloyd-Jones Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
5. A. Kulik, R. Levin, M. Ruel, T.G. Mesana, D.H. Solomon, N.K. Choudhry Patterns and predictors of statin use after coronary artery bypass graft surgery J Thorac Cardiovasc Surg 134 2007 932 938
6. K. Okrainec, R. Platt, L. Pilote, M.J. Eisenberg Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials J Am Coll Cardiol 45 2005 177 184
7. P.J. Bradshaw, K. Jamrozik, I. Gilfillan, P.L. Thompson Preventing recurrent events long term after coronary artery bypass graft: suboptimal use of medications in a population study Am Heart J 147 2004 1047 1053
8. P.R. Belcher, A. Gaw, M. Cooper, M. Brown, D.J. Wheatley, G.M. Lindsay Are we negating the benefits of CABG by forgetting secondary prevention? J Hum Hypertens 16 2002 691 697
9. L.K. Newby, N.M. LaPointe, A.Y. Chen Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2006 203 212
10. D. Sengstock, P. Vaitkevicius, A. Salama, R.M. Mentzer Under-prescribing and non-adherence to medications after coronary bypass surgery in older adults: strategies to improve adherence Drugs Aging 29 2012 93 103
11. N. Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82 1992 703 710
12. A.S. Go, J. Yang, J.H. Gurwitz, J. Hsu, K. Lane, R. Platt Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice Arch Intern Med 168 2008 2415 2421
13. A.S. Go, J. Yang, L.M. Ackerson et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study 113 2006 2713 2723
14. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
15. A.S. Go, W.Y. Lee, J. Yang, J.C. Lo, J.H. Gurwitz Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111
16. J.V. Selby, G.T. Ray, D. Zhang, C.J. Colby Excess costs of medical care for patients with diabetes in a managed care population Diabetes Care 20 1997 1396 1402
17. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
18. A.S. Levey, J. Coresh, T. Greene Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
19. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
20. B.H. Fireman, L. Fehrenbacher, E.P. Gruskin, G.T. Ray Cost of care for patients in cancer clinical trials J Natl Cancer Inst 92 2000 136 142
21. K.A. Eagle, E. Kline-Rogers, S.G. Goodman Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study Am J Med 117 2004 73 81
22. A.S. Go, R.K. Rao, K.W. Dauterman, B.M. Massie A systematic review of the effects of physician specialty on the treatment of coronary disease and heart failure in the United States Am J Med 108 2000 216 226
23. U. Khanderia, K.A. Townsend, S.R. Erickson, J. Vlasnik, R.L. Prager, K.A. Eagle Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes Ann Pharmacother 42 2008 192 199
24. J.V. Huang, A.W. Casebeer, M.E. Plomondon Prescription-filling rates for key medications in Veterans Affairs patients after coronary artery bypass grafting Am J Health Syst Pharm 61 2004 1248 1252
25. J.B. Williams, E.R. Delong, E.D. Peterson, R.S. Dokholyan, F.S. Ou, T.B. Ferguson Jr Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice Circulation 123 2011 39 45
26. U. Khanderia, K.A. Townsend, K. Eagle, R. Prager Statin initiation following coronary artery bypass grafting: outcome of a hospital discharge protocol Chest 127 2005 455 463
27. H.Y. Lee, C.E. Cooke, T.A. Robertson Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge J Manag Care Pharm 14 2008 271 280
28. L.F. Hiratzka, K.A. Eagle, L. Liang, G.C. Fonarow, K.A. LaBresh, E.D. Peterson Atherosclerosis secondary prevention performance measures after coronary bypass graft surgery compared with percutaneous catheter intervention and nonintervention patients in the Get With the Guidelines database Circulation 116 2007 I207 I212
29. H.B. Bosworth, B.B. Granger, P. Mendys Medication adherence: a call for action Am Heart J 162 2011 412 424